278 related articles for article (PubMed ID: 25288144)
41. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
[TBL] [Abstract][Full Text] [Related]
42. Adverse drug reactions reporting: a questionnaire-based study on Egyptian pharmacists' attitudes following an awareness workshop.
Alraie NA; Saad AA; Sabry NA; Farid SF
J Eval Clin Pract; 2016 Jun; 22(3):349-55. PubMed ID: 26638825
[TBL] [Abstract][Full Text] [Related]
43. Pharmacists' Attitudes and Role in Diabetes Management in Kuwait.
Al Haqan AA; Al-Taweel DM; Awad A; Wake DJ
Med Princ Pract; 2017; 26(3):273-279. PubMed ID: 28114146
[TBL] [Abstract][Full Text] [Related]
44. Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross-Sectional Study.
Hu W; Tao Y; Lu Y; Gao S; Wang X; Li W; Jiang Q; Lin L; Sun F; Cheng H
Front Pharmacol; 2022; 13():823944. PubMed ID: 35392558
[No Abstract] [Full Text] [Related]
45. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists.
Generali JA; Danish MA; Rosenbaum SE
Ann Pharmacother; 1995 Apr; 29(4):365-9. PubMed ID: 7633012
[TBL] [Abstract][Full Text] [Related]
46. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
47. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
48. Physicians' and pharmacists' perception and practice of hospital pharmacist professional role in Egypt.
Said A; Hussain N; Abdelaty LN
Int J Pharm Pract; 2020 Oct; 28(5):491-497. PubMed ID: 32497350
[TBL] [Abstract][Full Text] [Related]
49. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
50. Pharmacists' perception of educational material to improve patient safety: A cross-sectional study on practices and awareness in Germany.
Said A; Freudewald L; Parrau N; Ganso M; Schulz M
Medicine (Baltimore); 2021 Mar; 100(11):e25144. PubMed ID: 33725997
[TBL] [Abstract][Full Text] [Related]
51. Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain.
Weidmann AE; Cunningham S; Gray G; Hansford D; McLay J; Broom J; Stewart D
Int J Clin Pharm; 2011 Aug; 33(4):627-33. PubMed ID: 21573977
[TBL] [Abstract][Full Text] [Related]
52. Clinical and conventional pharmacy services in Polish hospitals: a national survey.
Pawłowska I; Pawłowski L; Kocić I; Krzyżaniak N
Int J Clin Pharm; 2016 Apr; 38(2):271-9. PubMed ID: 26739130
[TBL] [Abstract][Full Text] [Related]
53. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
Zimmermann A; Gaworska-Krzeminska A; Flis A
Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
[TBL] [Abstract][Full Text] [Related]
54. Community pharmacists' attitudes towards medicines use reviews and factors affecting the numbers performed.
Latif A; Boardman H
Pharm World Sci; 2008 Oct; 30(5):536-43. PubMed ID: 18288585
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer health promotion in Qatar: a survey of community pharmacists' interests and needs.
El Hajj MS; Hamid Y
Int J Clin Pharm; 2013 Jun; 35(3):376-85. PubMed ID: 21153487
[TBL] [Abstract][Full Text] [Related]
56. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
Blake KB; Madhavan SS
Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
[TBL] [Abstract][Full Text] [Related]
57. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
58. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.
Toklu HZ; Uysal MK
Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373
[TBL] [Abstract][Full Text] [Related]
59. Assessing the knowledge, perception and practices of physicians and pharmacists towards medication reconciliation in Kuwait governmental hospitals: a cross-sectional study.
Lemay J; Bayoud T; Husain H; Sharma P
BMJ Open; 2019 Jun; 9(6):e027395. PubMed ID: 31209092
[TBL] [Abstract][Full Text] [Related]
60. The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions.
Basak R; Bentley JP; McCaffrey DJ; Bouldin AS; Banahan BF
Soc Sci Med; 2015 May; 132():181-9. PubMed ID: 25818379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
